[1] Velasco A J M. Mammary cancer[J]. Revista Médica Del Hospital General, 1965,28(5):357-360. [2] Bakker M F, de Lange S V, Pijnappel R M, et al. Supplemental MRI screening for women with extremely dense breast tissue[J]. New England Journal of Medicine, 2019,381(22):2091-2102. [3] Melnikow J, Fenton J J, Whitlock E P, et al. Supplemental screening for breast cancer in women with dense breasts:a systematic review for the U.S. preventive services task force[J]. Annals of Internal Medicine, 2016,164(4):268-278. [4] Chong A, Weinstein S P, McDonald E S, et al. Digital breast tomosynthesis:concepts and clinical practice[J]. Radiology, 2019,292(1):1-14. [5] James J J, Tennant S L. Contrast-enhanced spectral mammography (CESM)[J]. Clinical Radiology, 2018,73(8):715-723. [6] Helal M H, Mansour S M, Salaleldin L A, et al. The impact of contrast-enhanced spectral mammogram (CESM) and three-dimensional breast ultrasound (3DUS) on the characterization of the disease extend in cancer patients[J]. British Journal of Radiology, 2018,91(1087):20170977. [7] 邵志敏, 李俊杰. 2015版《中国抗癌协会乳腺癌诊治指南与规范》:外科部分解读[J]. 中华乳腺病杂志(电子版), 2016,10(1):1-5. [8] 荣小翠, 康一鹤, 吴勇超, 等. X线摄影对微钙化型乳腺癌病变范围的评估[J]. 中国医学影像学杂志, 2019,27(9):659-663. [9] Förnvik D, Kataoka M, Iima M, et al. The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre:breast density assessment and diagnostic performance in comparison with MRI[J]. European Radiology, 2018,28(8):3194-3203. [10] 张琦, 宋富桂, 吕哲昊, 等. 致密型乳腺对乳腺癌的影响及其补充筛查[J]. 放射学实践, 2020,35(6):806-809. [11] 李红蕊,赵鹏,肖杨, 等. DBT联合FFDM在乳腺癌诊断中的价值研究[J]. 现代肿瘤医学, 2019,27(24):4430-4433. [12] 杨柳, 李白艳, 郑欢露, 等. 增强能谱乳腺摄影与MRI诊断乳腺癌效能比较:Meta分析[J]. 中国医学影像技术, 2019,35(7):1038-1043. [13] 张征委, 金彪, 顾雅佳. 对比增强能谱乳腺X线摄影的诊断价值分析[J]. 肿瘤影像学, 2020,29(2):141-147. [14] 田林, 李玉娜, 胡啸, 等. 6种影像学技术在致密型乳腺诊断中的应用[J]. 分子影像学杂志, 2020,43(1):7-11. [15] Miglioretti D L, Abraham L, Lee C I, et al. Digital breast tomosynthesis:radiologist learning curve[J]. Radiology, 2019,291(1):34-42. [16] 秦锦霞, 赵玉年, 王慧华, 等. 全屏数字化乳腺摄影与数字乳腺断层摄影对致密性乳腺内乳腺癌诊断及乳腺钙化比较研究[J]. 河北医学, 2020,26(4):598-602. [17] Savaridas S L, Taylor D B, Gunawardana D, et al. Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors[J]. Clinical Radiology, 2017,72(12):1085.e1-1085.e9. |